Theilen et al., 1968 - Google Patents
Bovine leukemia: establishment and morphologic characterization of continuous cell suspension culture, BL-1Theilen et al., 1968
- Document ID
- 15999022454586797023
- Author
- Theilen G
- Rush J
- Nelson-Rees W
- Dungworth D
- Munn R
- Switzer J
- Publication year
- Publication venue
- Journal of the National Cancer Institute
External Links
Snippet
Attempts to establish cell suspension cultures from 10 leukemic cows led to the development of a successful method. By this procedure, a serial-passage suspension cell culture has been maintained for 7 months. The cells grew as individual free-floating cells without …
- 238000004114 suspension culture 0 title abstract description 15
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Moore et al. | Culture of human leukemia cells | |
| Golde et al. | Growth of human bone marrow in liquid culture | |
| Steinman et al. | Identification of a novel cell type in peripheral lymphoid organs of mice: I. Morphology, quantitation, tissue distribution | |
| Hamburger et al. | Direct cloning of human ovarian carcinoma cells in agar | |
| Metcalf | Hemopoietic colonies: in vitro cloning of normal and leukemic cells | |
| Burk et al. | Establishment of a human plasma cell line in vitro | |
| US5766944A (en) | T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments | |
| Berman et al. | Long-Term Tissue Culture of Human Bone Marrow: I. Report of Isolation of a Strain of Cells Resembling Epithelial Cells from Bone Marrow of a Patient with Carcinoma of the Lung | |
| Burstein et al. | Characteristics of murine megakaryocytic colonies in vitro | |
| Benyesh-Melnick et al. | Studies on human leukemia. I. Spontaneous lymphoblastoid transformation of fibroblastic bone marrow cultures derived from leukemic and nonleukemic children | |
| Theilen et al. | Bovine leukemia: establishment and morphologic characterization of continuous cell suspension culture, BL-1 | |
| Saxén et al. | Transmission and spread of embryonic induction: II. Exclusion of an assimilatory transmission mechanism in kidney tubule induction | |
| US7179643B2 (en) | Device and a process for expansion of haemopoeitic stem cells for therapeutic use | |
| L'Esperance et al. | Congenital neutropenia: in vitro growth of colonies mimicking the disease | |
| US6692958B2 (en) | Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations | |
| YAMAMOTO et al. | A PHA-culture method for cells from the renal tissue of teleosts | |
| Paulnock | Macrophages: Practical Approach Series | |
| CN110857435B (en) | Culture medium for culturing immune cells separated from cord blood and culture method thereof | |
| Moore et al. | ISOANTIGENS OF CULTURED HUMAN LYMPHOID CELLS¹ | |
| Sinkovics et al. | Cellular activities in tissue cultures of leukemic human bone marrow | |
| Soda et al. | Lymphoid crisis with T‐cell phenotypes in a patient with Philadelphia chromosome negative chronic myeloid leukaemia | |
| Galton et al. | Karyotypic and morphologic characterization of a serially transplanted human choriocarcinoma | |
| Gadeberg et al. | Isolation of human peripheral blood monocytes: a comparative methodological study | |
| Moritomo et al. | Establishment of a cell line with reticulo-endothelial characteristics from a rainbow trout spleen explant | |
| Press et al. | Qualitative differences in the lymphocyte phytohemagglutinin (PHA) response between the bone marrow and other lymphoid organs |